Not surprisingly, ERα low/negative (ERαlow/−) tumors are predictive of BCa patient endocrine resistance and poor prognosis as compared to BCa patients with higher ERα tumor levels [73,74,75,76,77]. The gene discussed is ESR1; the disease is neoplasm.